Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: Correlation of biological markers with clinical responses

Bone marrow stromal cells (BMSCs) have been used to treat acute graft-versus-host disease (GVHD) and other complications following allogeneic hematopoietic stem cell transplantation (SCT). We conducted a phase I trial using third party, early passage BMSCs for patients with steroid-refractory GVHD,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yin, Fang, Battiwalla, Minoo, Ito, Sawa, Feng, Xingmin, Chinian, Fariba, Melenhorst, Jan Joseph, Koklanaris, Eleftheria, Sabatino, Marianna, Stroncek, David, Samsel, Leigh, Klotz, Jeffrey, Hensel, Nancy F., Robey, Pamela G., Barrett, A. John
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3991733/
https://ncbi.nlm.nih.gov/pubmed/24452962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.1638
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires